Christopher John Kenney

Insider Reports History

Entity
Individual
Location
200 3650 Gilmore Way, Burnaby,, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher John Kenney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Medical Officer Stock Option (Right to Buy) 100K Mar 11, 2024 Direct
Xenon Pharmaceuticals Inc. Chief Medical Officer Common Shares 0 $9.85 Mar 24, 2023 Direct

Insider Reports Filed by Christopher John Kenney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Mar 24, 2023 1 -$24.5K 4 Mar 24, 2023 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Jan 21, 2022 1 $20.2K 4 Jan 21, 2022 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Aug 23, 2021 1 $0 4 Aug 25, 2021 Chief Medical Officer
XENE Xenon Pharmaceuticals Inc. Aug 23, 2021 0 $0 3 Aug 25, 2021 Chief Medical Officer